IMR Press / EJGO / Special Issues / 1606792796989

The Role of Biomarker in Gynecological Oncology

Submission deadline: 30 June 2021
Special Issue Editors
Francesco Plotti, MD, PhD
Campus Biomedico University of Rome, Rome, ltaly
Interests: Gynecologyc Oncology; Minimally Invasive Surgery; Preinvasive Disease; Tumor Markers
Special Issue Information

Dear Colleagues,

In the last 10 years, new markers for the management of gynecological tumors has entered powerfully in the world literature. Tumor markers are soluble glycoproteins that are found in the blood, urine, or tissues of patients with certain types of cancer. They are typically produced by tumor cells, but in some cases they may be produced by the body in response to malignancy or to certain benign conditions. Tumor markers are not elevated in all cancer patients, particularly patients with early-stage cancer. The various tumor markers differ in their usefulness for screening, diagnosis, prognosis, assessing therapeutic response, and detecting recurrence.The aim of this comprehesnsive review is to gather all the evidence reported in literature analysing the potential value of tumor markers in every step of the management of gynecologic cancers and evaluate the new possible strategies for targeting growth-dependent mechanisms involved in its pathogenesis.

Prof. Dr. Francesco Plotti

Guest Editor

Ovarian cancer
Endometrial cancer
Cervical cancer
Tumor markers
Follow up
Target therapy
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Open Access Original Research
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy
Plotti Francesco, Bartolone Martina, Terranova Corrado, Guzzo Federica, ... Angioli Roberto
Eur. J. Gynaecol. Oncol. 2021, 42(5), 844–849;
(This article belongs to the Special Issue The Role of Biomarker in Gynecological Oncology)
Back to top